Century Therapeutics (IPSC) Other Operating Expenses (2020 - 2025)

Century Therapeutics (IPSC) has 5 years of Other Operating Expenses data on file, last reported at $6.8 million in Q3 2025.

• Other Operating Expenses for Q3 2025 came in at $6.8 million, up 754.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.8 million (up 17.93% YoY), and the FY2025 annual result was $6.8 million, up 2.64% from the prior year.
• Other Operating Expenses improved to $6.8 million in Q3 2025 per IPSC's latest filing, from $4.2 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $13.1 million in Q4 2023 and troughed at $99000.0 in Q2 2023.
• A 4-year average of $4.5 million and a median of $2.5 million in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses slumped 68.25% in 2024, then jumped 754.99% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at $10.0 million in 2022, then surged by 31.45% to $13.1 million in 2023, then tumbled by 68.25% to $4.2 million in 2024, then soared by 62.07% to $6.8 million in 2025.
• Business Quant data shows IPSC's Other Operating Expenses at $6.8 million in Q3 2025, $4.2 million in Q4 2024, and $791000.0 in Q3 2024.